Literature DB >> 8778420

Apparent heparin resistance form elevated factor VIII in a patient with postoperative deep venous thrombosis. A case report.

F D Cirisano1, S Lee, J S Greenspoon.   

Abstract

BACKGROUND: During the puerperium, heparin levels, rather than the adjusted partial thromboplastin time test, can be used to identify heparin resistance and guide heparin therapy. CASE: A patient receiving heparin for deep venous thrombosis had artifactual resistance to heparin, with a short adjusted partial thromboplastin time due to elevation of factor VIII. Heparin assay revealed a heparin level above the therapeutic range.
CONCLUSION: Direct measurement of heparin concentration and factor VIII activity should be performed when heparin resistance is suspected.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8778420

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  4 in total

1.  Apparent heparin resistance in a patient with infective endocarditis secondary to elevated factor VIII levels.

Authors:  Ramya Thota; Apar Kishor Ganti; Shanmuga Subbiah
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

2.  Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study.

Authors:  John A Heit; Brian D Lahr; Aneel A Ashrani; Tanya M Petterson; Kent R Bailey
Journal:  Thromb Res       Date:  2015-06-24       Impact factor: 3.944

3.  Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study.

Authors:  John A Heit; Brian D Lahr; Tanya M Petterson; Kent R Bailey; Aneel A Ashrani; L Joseph Melton
Journal:  Blood       Date:  2011-09-02       Impact factor: 22.113

4.  To be or not to be a case of heparin resistance.

Authors:  Jibran Durrani; Faizan Malik; Naveed Ali; Syed Imran Mustafa Jafri
Journal:  J Community Hosp Intern Med Perspect       Date:  2018-06-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.